Fact-checked by Grok 2 weeks ago

Hepadnaviridae

The Hepadnaviridae is a of small, enveloped viruses possessing a partially double-stranded, circular genome of approximately 3.0–3.4 kb, which replicates via reverse transcription of an intermediate within the host and . These hepatotropic viruses infect a diverse range of hosts, including , reptiles, amphibians, birds, and mammals, often establishing transient or persistent infections in the liver. The family is classified into five genera—Parahepadnavirus, Metahepadnavirus, Herpetohepadnavirus, Avihepadnavirus, and Orthohepadnavirus—encompassing over 30 species as of recent taxonomic updates. The most notable member is (Hepatitis B virus, genus Orthohepadnavirus), which infects humans and other and is a major global . Virions of Hepadnaviridae are spherical, measuring 42–50 nm in diameter, with an outer lipid envelope derived from the host cell membrane studded by surface glycoproteins (large, middle, and major surface proteins in mammalian viruses). Inside the envelope lies an icosahedral nucleocapsid composed of core protein subunits, enclosing the relaxed circular DNA genome bound to the viral polymerase. The genome organization is compact, featuring three to four open reading frames that encode essential proteins: the core/precore protein for capsid formation, the polymerase for reverse transcription, the surface proteins for envelopment, and an additional X protein in orthohepadnaviruses that modulates host responses. Transcription from the covalently closed circular DNA (cccDNA) intermediate—a stable nuclear minichromosome—produces multiple pregenomic and subgenomic RNAs that serve as mRNAs and templates for replication. Replication is distinctive among DNA viruses, initiating with uncoating and nuclear import of the partially double-stranded genome, which is repaired to by host enzymes; this form persists and drives chronic infections. In the cytoplasm, the polymerase reverse-transcribes the pregenomic RNA into DNA within assembling nucleocapsids, followed by envelopment and secretion of mature virions. Host range is genus-specific: Parahepadnavirus and Metahepadnavirus infect , Herpetohepadnavirus targets reptiles and amphibians (e.g., Tibetan frog hepatitis B virus), Avihepadnavirus affects birds (e.g., duck hepatitis B virus), and Orthohepadnavirus primarily mammals (e.g., woodchuck hepatitis virus). Infections by Hepadnaviridae members often lead to liver inflammation (), with potential progression to , , and due to viral persistence, immune-mediated damage, and oncogene integration. alone chronically infects an estimated 254 million people worldwide as of 2022, resulting in approximately 1.1 million deaths in 2022 from liver-related complications, underscoring its significance. Other members, such as avihepadnaviruses, cause similar hepatic pathologies in avian hosts, serving as models for studying human mechanisms. Preventive vaccines exist for , but therapeutic challenges persist due to stability and viral evasion of immunity.

Taxonomy

Classification Hierarchy

The family Hepadnaviridae is classified within the realm , which encompasses viruses that encode RNA-dependent polymerases for replication, including those utilizing . Within , Hepadnaviridae belongs to the kingdom Pararnavirae, Artverviricota, Revtraviricetes, and Blubervirales, where it stands as the sole . This placement reflects the evolutionary between the hepadnavirus and RNA-directed RNA polymerases of RNA viruses, justifying their inclusion in despite their DNA genomes. Historically, Hepadnaviridae was initially classified without higher-order ranks beyond the family level in early ICTV reports, but recent taxonomic expansions elevated it to the order Blubervirales in the 2020 ICTV update, aligning it with the realm to better capture shared replicative mechanisms across RNA and reverse-transcribing viruses. This shift, proposed based on phylogenetic analyses of domains, marked a significant restructuring from prior unranked status, emphasizing the ancient origins of reverse transcription in . No major reclassifications have occurred since, though ongoing ICTV efforts continue to refine boundaries within Revtraviricetes.

Genera and Species

The family Hepadnaviridae is divided into five genera, each primarily delineated by host range, with further distinctions based on genomic features such as the presence or absence of specific open reading frames (ORFs) and overall sequence divergence exceeding 40% between genera. In 2023, the ICTV approved binominal for all and added nine new , bringing the family total to 27 as of 2025. These genera reflect the family's broad host specificity across vertebrates, from to mammals, though serological is generally low between genera. Avihepadnavirus comprises viruses that infect avian species and now includes five species following 2023 additions. Key species include Duck avihepadnavirus (formerly Duck hepatitis B virus; DHBV), which primarily affects ducks and has been detected in related birds like geese; Heron avihepadnavirus (HHBV), found in herons; Parrot avihepadnavirus (PHBV), associated with parrots; Stork avihepadnavirus (STHBV), from white storks; and Crane avihepadnavirus (CHBV), from grey crowned cranes. These viruses share greater than 80% genome sequence similarity within the genus. Herpetohepadnavirus includes viruses infecting reptiles and amphibians, notably poikilothermic hosts. The sole recognized species is Tibetan frog hepadnavirus (formerly Tibetan frog hepatitis B virus; TFHBV), isolated from Tibetan frogs, characterized by the absence of an X ORF typical of some other hepadnaviruses. Metahepadnavirus encompasses viruses from fish, distinguished by their compact genomes lacking the X ORF. The exemplar species is metahepadnavirus (formerly Bluegill hepatitis B virus; BGHBV), identified in fish, with sequence data supporting its isolation as a distinct entity based on environmental and host sampling. Orthohepadnavirus contains the most species (19 as of 2023), infecting mammals, including primates and rodents, and features the presence of an X ORF in many members. Prominent examples are Human orthohepadnavirus (formerly Hepatitis B virus; HBV), which infects humans and apes and is divided into multiple genotypes with less than 20% divergence; Woodchuck orthohepadnavirus (WHV), from woodchucks (a rodent model for HBV research); and Ground squirrel orthohepadnavirus (GSHV), from ground squirrels. Other species include Woolly monkey orthohepadnavirus (WMHBV) and various primate-, bat-, and rodent-specific variants. Species demarcation within this genus relies on approximately 20% nucleotide divergence in complete genomes, alongside limited serological cross-reactivity. Parahepadnavirus also targets fish but differs from Metahepadnavirus in and sequence identity. The representative species is White sucker parahepadnavirus (formerly White sucker hepatitis B virus; WSHBV), detected in fish, with virion particles confirmed in infected hosts. This genus highlights the ancient divergence of hepadnaviruses in aquatic vertebrates.

History

Discovery of Key Members

The discovery of the Australia by Baruch S. Blumberg in 1965 represented the first key identification of a component of what would become recognized as the (HBV), the prototype species of the Hepadnaviridae family. Blumberg's team detected this antigen in the of an Aboriginal donor while screening for polymorphisms in serum proteins among diverse populations, initially observing it in patients with and later associating it with transfusion-related cases. This serendipitous finding, reported in a preliminary communication, highlighted the antigen's presence in individuals with , Down's syndrome, and certain malignancies, laying the groundwork for linking it to viral etiology. By 1967–1968, further studies confirmed the Australia antigen's association with hepatitis B infections, with its identification as the hepatitis B surface antigen (HBsAg) solidified through immunological assays showing its correlation with acute and chronic serum hepatitis. Blumberg's work earned him the in or Medicine in 1976 for this breakthrough, which enabled serological screening of blood donors and dramatically reduced post-transfusion hepatitis transmission. In the early 1970s, electron provided the first visual confirmation of HBV virions, described as 42-nm double-shelled particles (later termed Dane particles) alongside smaller 22-nm spherical and tubular forms in sera from HBsAg-positive patients. Parallel efforts in 1980 led to the isolation of duck hepatitis B virus (DHBV) from domestic Pekin ducks in , establishing the first animal model for hepadnaviral infection and facilitating experimental studies inaccessible with human HBV. DHBV, sharing structural and replicative features with HBV, was isolated from viremic ducklings in a research institute, revealing persistent infections that mimicked human chronic . This model proved invaluable for research. Key molecular milestones followed in the late 1970s and early , including the of the HBV in 1979, which allowed for the first complete sequencing and enabled detailed genetic analyses. This achievement, using technology on HBV DNA extracted from infected liver tissue, confirmed the virus's partially double-stranded circular DNA structure and opened avenues for vaccine development and antiviral research. Concurrently, studies on DHBV in the early demonstrated that hepadnaviruses replicate via reverse transcription of a pregenomic intermediate, a mechanism analogous to retroviruses but distinct in its DNA-based , building on David Baltimore's 1970 discovery of in retroviruses. These insights, derived from and animal model experiments, fundamentally shaped understanding of hepadnaviral replication.

Taxonomic Development

The taxonomic development of Hepadnaviridae began in the and with the initial recognition of (HBV) and related animal viruses as a distinct group of hepatotropic DNA viruses, initially classified among unassigned DNA viruses due to their unique partially double-stranded circular genome and reverse transcription replication strategy. Key discoveries included the identification of woodchuck hepatitis virus (WHV) in 1978, which showed striking similarities to HBV in structure and liver tropism, and duck hepatitis B virus (DHBV) in 1980, establishing avian analogs that highlighted shared features across mammalian and bird hosts. These findings prompted informal proposals for a new family, emphasizing the viruses' hepatic affinity ("hepa-") and DNA nature ("-dna"), though formal classification remained pending as they were provisionally grouped with other unclassified double-stranded DNA viruses. In the 1990s, the International Committee on Taxonomy of Viruses (ICTV) formally established the family Hepadnaviridae through ratified proposals in 1990, recognizing it as a distinct for these enveloped, reverse-transcribing es. This establishment included the creation of two initial genera: Orthohepadnavirus for mammalian-infecting members like HBV and WHV, and Avihepadnavirus for avian viruses such as DHBV, based on host range, genome organization, and phylogenetic relationships. The classification reflected the family's defining traits, including relaxed circular DNA genomes of 3.0–3.4 kb and hepatocyte-specific replication, solidifying Hepadnaviridae's position outside other families like or Papovaviridae. From the 2010s to 2025, taxonomic expansions reflected advances in viral discovery and genomics, leading to the addition of three new genera in 2019—Parahepadnavirus, Metahepadnavirus, and Herpetohepadnavirus—bringing the total to five, as ratified by the ICTV in 2020 to accommodate diverse lineages from fish, amphibians, reptiles, and other hosts identified through metagenomics. These additions, such as Parahepadnavirus for fish viruses and Herpetohepadnavirus for amphibian and reptilian members, were justified by distinct phylogenetic clades and host specificities, expanding the family's scope beyond ortho- and avihepadnaviruses. The 2024 ICTV taxonomy release further standardized nomenclature by adopting binomial species names across Hepadnaviridae, aligning with the ICTV's global mandate for uniform format (e.g., Hepatitis B virus for the type species), completing a phased transition initiated in 2021 to enhance clarity and consistency in viral classification.

Virion Structure

Overall Morphology

The virions of the Hepadnaviridae family are spherical, enveloped particles measuring approximately 42–50 nm in diameter, featuring a envelope derived from host cell membranes that surrounds an internal nucleocapsid . These enveloped structures, known as Dane particles in the case of (HBV), represent the complete infectious form of the virus. In contrast, the non-enveloped capsids measure about 36 nm in diameter and consist of the protein shell without the outer layer. The s display icosahedral characterized by a triangulation number of T=4, enabling the assembly of a robust that packages the viral genome. This arises from the arrangement of 120 dimeric subunits of the core protein, forming a stable icosahedral . Cryo-electron microscopy (cryo-EM) studies have elucidated this architecture, revealing the precise positioning of subunits and the overall geometry of the at near-atomic . The relaxed circular, partially double-stranded DNA genome is encapsidated within the capsid, protected by its structural integrity. Hepadnaviridae virions and capsids exhibit stability in harsh environments such as bile and feces, allowing persistence outside the host.

Capsid

The capsid of Hepadnaviridae viruses, exemplified by hepatitis B virus (HBV), is composed primarily of the core antigen (HBcAg or Cp), a single major structural protein of approximately 183-185 amino acids that forms the nucleocapsid core. This protein self-assembles into an icosahedral structure with triangulation number T=4 symmetry, measuring about 36 nm in diameter and consisting of 120 dimers (240 monomers) arranged in a shell that encloses the viral genome. Immature or empty capsids may adopt T=3 symmetry with 90 dimers (180 monomers), but the mature, genome-containing form predominantly exhibits T=4 organization. Assembly of the begins with the formation of dimers, stabilized by a four-helix bundle involving α-helices 3 and 4 in the N-terminal domain (NTD), followed by cooperative dimer-dimer interactions driven by hydrophobic contacts at the "hand" region (α-helix 5). The NTD, which is all-α-helical and spans residues 1-140, primarily directs this icosahedral , while the flexible C-terminal domain (CTD, residues 150-183/185) remains internally positioned during initial formation. The CTD is -rich, containing 16 basic residues that enable specific binding to the pregenomic (pgRNA) for selective genome during . The plays a critical role in nuclear import, facilitated by nuclear localization signals (NLS) within the Cp CTD, particularly the monopartite NLS sequence (residues 168-175: SQSPRRRR) that binds α1 at its major binding pocket. Up to 30 α1/β1 heterodimers can attach to the at quasi-sixfold vertices via exposed NLS protruding through 9-13 Å pores, enabling transport through the nuclear pore complex (NPC) despite the capsid's ~360 Å diameter nearing the NPC's ~690 Å limit. maturation involves of serine residues (e.g., S155, S162, S170) in the CTD by host protein phosphatase 1 (PP1), which stabilizes the structure, externalizes the CTD for NLS exposure, and promotes compaction while suppressing non-specific RNA interactions to facilitate pgRNA encapsidation and reverse transcription. This post-assembly modification is essential for the 's transition from immature to mature states, preparing it for nuclear delivery of the relaxed circular DNA genome.

Envelope

The envelope of Hepadnaviridae virions consists of a derived from the , acquired during viral at post-endoplasmic reticulum and pre-Golgi compartments. This bilayer incorporates host , comprising approximately 30–40% phospholipids, , cholesterol esters, and triglycerides, which contribute to the envelope's stability and flexibility. Embedded within the are three related glycoproteins designated as large (L), middle (M), and small (S) surface antigens, referred to as in the case of (HBV). The L protein is myristoylated at its and predominates in mature virions and filamentous forms, where it assembles into disulfide-linked dimers that mediate receptor binding. The M protein, present primarily in orthohepadnaviruses, includes a preS2 domain, while the S protein is the major component of non-infectious subviral particles, such as 17–22 nm spheres and filaments. These glycoproteins span the envelope via two transmembrane domains and feature an antigenic loop stabilized by disulfide bonds, with N-linked glycosylation sites that influence particle secretion and immunogenicity. The , measuring approximately 8 nm in thickness, encases the nucleocapsid, providing protection against environmental degradation while enabling virion attachment through interactions of the surface proteins with host factors.

Genome

Structure and Organization

The genome of Hepadnaviridae viruses is a partially double-stranded, relaxed circular DNA (rcDNA) molecule, typically 3.0–3.4 kb in length. The longer negative-sense strand measures approximately 3.2 kb and is fully base-paired at both ends, while the shorter positive-sense strand is incomplete, extending variably from about 50% to 95% of the full length depending on the virus and replication stage. This asymmetry results in single-stranded regions that are repaired in the host nucleus to form covalently closed circular DNA (cccDNA), the persistent template for viral transcription. The genomic architecture is remarkably compact, with overlapping open reading frames (ORFs) that maximize coding capacity within the limited size; for instance, orthohepadnaviruses like (HBV) encode core, polymerase, surface, and X proteins from partially overlapping sequences. Critical regulatory elements include two direct repeats (DR1 and DR2), short sequences of 8–11 located near the 5' end of the positive strand, which facilitate priming during reverse transcription. Cohesive ends—short, complementary overhangs of 8–12 at the 5' termini of the strands—enable base-pairing to stabilize the circular form without covalent linkage. Hepadnaviridae genomes exhibit distinct epigenetic features adapted to their hosts, including marked suppression of CpG dinucleotides compared to other DNA viruses, which reduces immune recognition by host pattern recognition receptors. The DNA lacks introns, consistent with its prokaryote-like, continuous structure that relies on post-transcriptional processing of pregenomic RNA for protein diversity. Mammalian members, such as those in the genus Orthohepadnavirus, show elevated GC content of approximately 48–50%, higher than the typical 40–42% in vertebrate host genomes, contributing to secondary structure stability.

Open Reading Frames

The genomes of Hepadnaviridae viruses contain three to four major overlapping open reading frames (ORFs) that collectively encode the core structural, enzymatic, and envelope proteins necessary for the viral life cycle, with orthohepadnaviruses additionally encoding a regulatory X protein. This compact genetic architecture maximizes coding efficiency within the partially double-stranded circular DNA genome of approximately 3.0–3.4 kb. The polymerase (P) ORF overlaps the other ORFs, spanning nearly the entire genome, while the precore/core (preC/C), envelope (preS1/preS2/S), and X ORFs (in orthohepadnaviruses) are nested within or partially overlap it, often sharing sequence elements that constrain evolutionary divergence. The preC/C ORF, approximately 600 bp in length, encodes the multifunctional core protein ( in orthohepadnaviruses, approximately 180 ) responsible for nucleocapsid assembly, as well as the precore protein via an upstream AUG , which is post-translationally processed into the soluble e (HBeAg). This ORF overlaps the 3' end of the P ORF by about 23% of its sequence. The P ORF, roughly 2.6 kb long and encoding a ~800- multifunctional polymerase with terminal protein, , and RNase H domains, is translated from a bicistronic pregenomic transcript shared with the preC/C ORF; translation initiates internally via ribosomal shunting, ensuring low-level expression relative to the core protein. Its extensive overlap with other ORFs—fully encompassing the preS/S ORF and partially overlapping preC/C and X—highlights the family's evolutionary reliance on compression. The preS/S ORF, about 1.2 kb in length, utilizes multiple in-frame start codons to produce three nested glycoproteins from bicistronic or subgenomic transcripts: the small surface protein (S, ~226 ), middle surface protein (M, with an N-terminal preS2 extension of ~55 ), and large surface protein (L, with additional preS1 and preS2 domains totaling ~389 in some subtypes). These proteins form the and mediate host attachment, with the full ORF completely nested within the P ORF. The X ORF, approximately 450 bp and encoding a ~154-amino-acid regulatory protein (HBx in orthohepadnaviruses), is present only in orthohepadnaviruses, where it overlaps the preC/C and P ORFs by up to 39% of its length and enhances viral transcription and replication through interactions with host factors.

Viral Polymerase

The viral polymerase of Hepadnaviridae, also known as protein P, is encoded by the P open reading frame and functions as a multifunctional enzyme essential for genome replication. It comprises four distinct domains: the terminal protein (TP) domain, which serves as a primer for reverse transcription by providing a tyrosine residue for nucleotide attachment; the spacer domain, which links the TP to the catalytic regions and may influence protein interactions; the reverse transcriptase (RT) domain, responsible for RNA-dependent DNA synthesis; and the RNase H domain, which degrades the RNA template during DNA synthesis. This polymerase exhibits multiple enzymatic activities, including RNA-dependent DNA polymerase activity via the RT domain, DNA-dependent DNA polymerase activity for completing the viral DNA, and ribonuclease H activity to remove RNA from RNA-DNA hybrids. A key feature is the covalent attachment of the TP domain to the 5' end of the minus-strand DNA, which occurs during priming and stabilizes the nascent DNA product. Structural studies, primarily through and predicted atomic models due to challenges in crystallizing the full enzyme, reveal that the domain adopts a classic right-hand fold characteristic of retroviral reverse transcriptases, with fingers, , and subdomains that facilitate template binding and incorporation. For instance, in (HBV), the subdomain contains conserved motifs (A, B, C, D) critical for , while the fingers and ensure during . The is a primary target for antiviral therapies, showing sensitivity to nucleoside analogs such as lamivudine, which competitively inhibit the domain by mimicking natural substrates and terminating chain elongation. can emerge through mutations in the domain, particularly in the YMDD , underscoring the enzyme's role in therapeutic challenges.

Surface Antigens

The surface antigens of Hepadnaviridae are encoded by the surface (ORF), which produces glycoproteins essential for virion , , and host interaction. In orthohepadnaviruses, such as (HBV), the surface ORF is divided into three regions: preS1 (upstream), preS2 (middle), and S (downstream), spanning approximately 1.2 kb and overlapping the ORF. initiation at distinct ATG codons within this ORF generates three co-terminal proteins: the large (L) protein (full preS1 + preS2 + S, ~389 ), middle (M) protein (preS2 + S, ~281 ), and small (S) protein (S only, ~226 ). The S domain is highly conserved across the , forming the core structural unit for formation, while the preS1 domain is critical for viral by mediating receptor binding on host hepatocytes. In contrast, avihepadnaviruses, such as duck hepatitis B virus (DHBV), lack a distinct preS2 region and instead encode only L (preS + S) and S proteins from a simpler preS/S ORF, reflecting evolutionary divergence but retaining analogous functions in production. These glycoproteins exhibit post-translational modifications that stabilize their structure and influence antigenicity. All three proteins in orthohepadnaviruses are type II transmembrane proteins with N-linked sites: the M protein at Asn4 in preS2 and the S protein at Asn146, facilitating proper folding and , though is dispensable for subviral particle formation but required for efficient virion . The S contains a cysteine-rich major hydrophilic region (MHR, residues 99–169) with up to 12 conserved cysteines forming intramolecular bonds, which maintain the protein's antigenic conformation and enable association during . Genotype-specific variants arise primarily in the preS and S regions, altering and transmission; for instance, the HBV ayw subtype (common in D) features distinct motifs in the MHR (e.g., at position 122), which can modulate recognition compared to the adw subtype. Such variants contribute to serological across the eight HBV genotypes (A–H) and influence escape or progression. Overexpression of the S protein during leads to the of non-infectious subviral particles (SVPs), predominantly 22 nm spherical or filamentous structures composed almost entirely of S (and some M) glycoproteins embedded in a . These SVPs vastly outnumber virions (by 1,000- to 100,000-fold) in and serve as decoys that bind anti-surface antigen antibodies, thereby facilitating immune evasion and contributing to chronic persistence by overwhelming humoral responses and suppressing activation. In avihepadnaviruses, analogous SVPs form via S protein alone, underscoring the conserved role of the S domain in particle across the .

Replication Cycle

Attachment and Entry

The attachment of hepadnaviruses to host cells is mediated by the PreS1 domain of the large (L) surface protein, which binds specifically to the sodium taurocholate cotransporting polypeptide (NTCP) receptor expressed on the basolateral membrane of hepatocytes. This interaction is essential for initiating infection in orthohepadnaviruses, such as (HBV), where the N-terminal myristoylated PreS1 peptide (myr-PreS1) serves as the primary determinant for receptor recognition. Following attachment, hepadnaviruses enter hepatocytes via clathrin-mediated , a that is independent of low pH and involves sequential sorting through early and late endosomes. The exposure of the myristoylated N-terminus of PreS1 during this endocytic uptake facilitates tight binding to NTCP, enabling viral internalization without reliance on acidification for membrane fusion. Host range specificity for orthohepadnaviruses is largely determined by sequence variations in the NTCP receptor, which restrict infection to mammalian while excluding broader hosts. For instance, adaptive changes in NTCP sequences enhance susceptibility to HBV-like viruses, underscoring the role of receptor evolution in limiting among mammals.

Nuclear Replication

Following entry into the host hepatocyte, the hepadnavirus capsid is transported to the nucleus through interactions with importins, specifically karyopherin α and β, which recognize nuclear localization signals on the capsid protein or the covalently attached viral polymerase. This active transport occurs via the nuclear pore complex, enabling the intact capsid to reach the nuclear basket. Once in the nucleus, the capsid undergoes partial uncoating, releasing the relaxed circular partially double-stranded DNA (rcDNA) genome into the nucleoplasm. The released rcDNA, which contains lesions such as a protein covalently bound to the 5' end of the minus strand, an RNA primer on the plus strand, and incomplete plus-strand synthesis, is repaired by host cellular factors to form the covalently closed circular DNA (cccDNA). This repair process involves tyrosyl-DNA phosphodiesterase 2 (TDP2) for removal of the covalently attached polymerase, flap endonuclease 1 (FEN1) for processing the RNA primer and terminal redundancy, host DNA polymerases such as polymerase δ (POLδ) for gap filling, and DNA ligases (LIG1 or LIG3) for nick sealing. These host enzymes convert the rcDNA into a stable, episomal cccDNA molecule, which serves as the viral transcription template without integration into the host genome. The associates with host histones to form a minichromosome-like structure in the , recruiting host transcription factors and serving as the for viral synthesis by host . Transcription is regulated by four distinct promoters: the core or pregenomic promoter, which directs synthesis of the pregenomic (pgRNA) that functions both as mRNA for core and proteins and as the for reverse transcription; the preS1 promoter for the large surface protein mRNA; the S promoter for the middle and small surface protein mRNAs; and the X promoter for the X protein mRNA. These transcripts are polyadenylated and exported to the for translation and replication. The episomal nature of allows it to persist in the of infected hepatocytes, maintaining a that sustains even under immune pressure or antiviral therapy, with typically 5–30 copies per cell. Its stability is reflected in a of 30–50 days in non-dividing hepatocytes.

Reverse Transcription

Reverse transcription in Hepadnaviridae represents a distinctive RNA-directed DNA polymerization process that occurs within the viral , converting the pregenomic RNA (pgRNA) into partially double-stranded relaxed circular DNA (rcDNA). This , unique among viruses, relies on the multifunctional viral , which encompasses terminal protein (TP), (RT), and RNase H domains, to initiate and complete using the pgRNA as template. The process is tightly regulated by nucleocapsid states and begins shortly after packaging of the polymerase-pgRNA complex into newly assembled particles. The -pgRNA complex is selectively packaged into immature capsids through specific RNA encapsidation signals, such as the 5' ε stem-loop that binds the 's TP . Once encapsidated, protein priming initiates reverse transcription: a conserved residue in the TP forms a with the first , synthesizing a short (typically dG or dGT) linked to the protein. This priming step requires the ε template and is enhanced by divalent metal ions like Mn²⁺, which facilitate the induced-fit conformation of the - complex. Minus-strand DNA synthesis proceeds by translocation of the primed polymerase to the 3' direct repeat DR1/DR2 regions on the pgRNA, where the RT domain extends the nascent DNA strand using the pgRNA as template, producing a full-length minus-strand DNA covalently attached to the TP. Concurrently, the RNase H domain degrades the RNA template in a 5'-3' manner, leaving a poly-A tail and removing most RNA except for the 5' rG residues that prime plus-strand synthesis. Plus-strand synthesis initiates near the DR1 region, utilizing a flap structure formed by the displaced RNA for template switching, but remains incomplete, resulting in the characteristic gapped rcDNA structure with overlapping ends. The error-prone nature of the hepadnaviral , lacking 3'-5' activity, introduces mutations at a rate of approximately 3.2 × 10⁻⁵ substitutions per site per replication cycle, fostering diversity that contributes to immune evasion and adaptation.

Assembly and Release

In hepadnaviruses, the assembly of infectious virions initiates in the with the formation of immature nucleocapsids that package the pregenomic (pgRNA) and viral polymerase. These immature capsids, composed of 240 copies of the core protein (120 dimers) arranged in a T=4 icosahedral , recruit envelope proteins at the () via specific interactions between the core protein's major domain and the preS regions of the large surface antigen (L-HBsAg). During recruitment, the capsids bud into the , acquiring a host-derived through the lipidation and integration of the envelope glycoproteins in a post-/pre-Golgi compartment. Following envelopment, the particles mature as reverse transcription completes within the to form the relaxed circular DNA (rcDNA) genome, resulting in fully infectious virions of 42–50 nm in . These mature virions are secreted from the via multivesicular bodies (MVBs), a process mediated by host endosomal sorting complexes required for transport (), particularly ESCRT-III and Vps4, which facilitate the final budding step into the . Hepadnaviruses also produce non-infectious subviral particles (SVPs) in vast excess—often 1,000-fold more than virions—composed primarily of the small surface (S-HBsAg) and appearing as 17–22 nm spheres or filamentous structures. These SVPs assemble independently in the and are secreted through the constitutive secretory pathway via the Golgi apparatus, functioning as immune decoys to divert responses and promote viral persistence. A portion of non-infectious enveloped particles or naked mature nucleocapsids is recycled intracellularly rather than secreted, trafficking back to the to deliver rcDNA for replenishment of the covalently closed circular DNA () pool; this recycling is regulated by of the core protein's arginine-rich carboxy-terminal domain, which modulates nuclear localization signals. Mutations in the core protein can disrupt and release; for instance, substitutions in the major domain (e.g., F97L or I126A) impair envelope recruitment and lead to intracellular accumulation of unenveloped capsids, while alterations in the linker region (e.g., L143I) delay virion maturation and secretion, often increasing levels by promoting over egress.

Evolution

Phylogenetic Origins

The family Hepadnaviridae has ancient origins, with endogenous viral elements (EVEs) providing molecular fossils that trace the group's evolutionary history deep into the era. Analysis of avian genomes has revealed multiple integrations of hepadnavirus-derived sequences dating back more than 82 million years ago (), indicating that avihepadnaviruses were circulating in bird lineages well before the diversification of modern orders. These EVEs, including full-length viral genomes in some cases, include integrations in reptilian genomes dating back more than 207 , predating the mammal-bird estimated at approximately 310 , while avian-specific EVEs date to more than 82 , suggesting a long association with hosts. Similarly, metahepadnavirus EVEs have been identified in genomes, supporting an even earlier emergence of hepadnavirus-like viruses in vertebrates, with some integrations predating the -tetrapod split over 400 . Phylogenetic evidence points to co-speciation between Hepadnaviridae and their hosts, where lineages have diverged in parallel with host radiations over tens of millions of years. For instance, the deep branching patterns in gene phylogenies align with host phylogenies, implying ancient codivergence rather than frequent host jumps. This co-evolutionary dynamic is further evidenced by the distribution of EVEs across reptiles, , and , which reflect host-specific clades that have persisted since the era. An ancient ancestor is proposed for Hepadnaviridae, given their unique replication strategy involving protein-primed reverse transcription of a pregenomic intermediate—a hallmark of retroelement that likely originated in RNA-based viruses before the acquisition of a DNA phase. Molecular clock analyses, calibrated using EVE insertion dates, estimate divergence times that mirror major host evolutionary events. The split between orthohepadnaviruses (mammalian viruses) and avihepadnaviruses is placed around 50 MYA, coinciding with the radiation of placental mammals during the Eocene. Overall substitution rates derived from these ancient calibrations are low, approximately 2.59 × 10^{-9} substitutions per site per year, underscoring the evolutionary stability of hepadnaviruses over geological timescales. These estimates highlight how Hepadnaviridae have maintained a conserved genomic while adapting to diverse vertebrate hosts through co-speciation.

Host Adaptation and Diversity

The family Hepadnaviridae exhibits remarkable host specificity, with its five genera each adapted to distinct classes, underscoring a history of co-evolution with hosts over geological timescales. The genus Orthohepadnavirus primarily infects mammals, including , , and other species such as woodchucks; Avihepadnavirus is restricted to , with examples like ; Herpetohepadnavirus targets reptiles and amphibians; while Metahepadnavirus and Parahepadnavirus are associated with fish, such as bluegill hepatitis B virus and white sucker hepatitis B virus, respectively. This partitioning reflects cospeciation, where viral lineages have diverged alongside their hosts, resulting in intergenic identities of approximately 55% across genera. Such adaptations likely stem from specialized interactions with host entry receptors, like the sodium taurocholate cotransporting polypeptide in mammals, enabling persistent hepatotropic infections while limiting cross-species transmission. Within the Orthohepadnavirus genus, genetic diversity is pronounced, particularly in (HBV), which is classified into ten genotypes (A–J) based on greater than 8% divergence across the full genome. These genotypes show geographic clustering, with A and D prevalent in and , B and C in , and others like E–J in specific regions, reflecting regional co-adaptation to populations. Recombination events further amplify this diversity, with hotspots identified in the preS/S region (encompassing the surface antigen gene) and the X gene, where breakpoints often occur at positions 3150–100, 650–830, 1770–1830, and 1920–1980. These recombinations, frequently between genotypes like A/D or B/C, enhance viral fitness by combining advantageous traits, such as altered antigenicity or replication efficiency, and occur at rates that contribute to 10–20% of circulating strains in high-diversity areas. Hepadnaviruses demonstrate zoonotic potential through occasional spillovers from non-primate mammals to , facilitated by genetic proximity within Orthohepadnavirus. For instance, rodent-associated orthohepadnaviruses, such as those identified in rice rats, share sequence similarities with HBVs, suggesting historical cross-species transmissions that may have contributed to early diversification. Additionally, hepadnaviruses exhibit phylogenetic links to HBVs, raising concerns for present-day zoonotic risks at human-animal interfaces. This diversity generates immune-evasion variants, particularly in the surface , where like G145R allow escape from neutralizing antibodies, complicating efficacy and enabling persistent infections across host shifts.

Relation to Nackednaviridae

In 2017, a new family of non-enveloped viruses termed Nackednaviridae was proposed based on metagenomic discovery of diverse fish viruses closely related to Hepadnaviridae. These viruses, identified primarily in teleost fish such as white suckers and more recently in African cichlids, exhibit a broader host association including amphibians like frogs. Nackednaviridae and Hepadnaviridae share key genomic and functional traits, including partially double-stranded, reverse-transcribing DNA genomes and polymerase proteins with conserved reverse transcriptase (RT) domains that enable protein-primed reverse transcription. Phylogenetic analyses place them as sister taxa, with an estimated divergence around 400 million years ago during the Silurian period, predating the tetrapod radiation. This ancient split highlights their common ancestry within the broader group of reverse-transcribing elements. The relationship implies that the Hepadnaviridae likely evolved after divergence, suggesting an ancestral non-enveloped form akin to modern nackednaviruses. Evidence from endogenous viral elements (EVEs) integrated into host genomes, such as those in lineages dating to 69–67 million years ago, further supports events and long-term co-evolution between these viral lineages and hosts.

Host Interactions

Natural Hosts and Range

The family Hepadnaviridae encompasses viruses with a narrow host range, primarily infecting vertebrates across diverse taxa. Members of the genus Orthohepadnavirus are predominantly associated with mammalian hosts. (HBV) naturally infects humans and is distributed worldwide, with an estimated 254 million chronic carriers as of 2022. Related orthohepadnaviruses infect non-human primates, including chimpanzees (Pan troglodytes), gorillas (Gorilla gorilla), orangutans (Pongo spp.), and gibbons (Hylobates spp.), with detections reported across and . hosts include woodchucks (Marmota monax) harboring woodchuck hepatitis virus (WHV), primarily in , and ground squirrels (Spermophilus beecheyi) infected with ground squirrel hepatitis virus (GSHV) in regions. Additionally, diverse orthohepadnaviruses have been identified in s, such as in the pomona roundleaf bat (Hipposideros pomona) in , and in other bat species in , , and , indicating a broader in chiropteran species across tropical and subtropical zones. The genus Avihepadnavirus comprises viruses that naturally infect avian species, with a global distribution reflecting bird migrations and trade. Duck hepatitis B virus (DHBV) is well-documented in domestic Pekin ducks (Anas platyrhynchos domesticus) and wild mallards (Anas platyrhynchos), with prevalence in Asia, Europe, and North America through vertical transmission in flocks. Other avihepadnaviruses occur in geese, herons (Ardea spp.), storks, cranes, and exotic waterfowl such as mandarin ducks (Aix galericulata) and puna teals (Anas flavirostris), often detected in wild populations across continents, including South America and Eurasia. These infections are maintained through both vertical and horizontal transmission, contributing to endemic patterns in migratory bird routes. Viruses in the genera Herpetohepadnavirus and Metahepadnavirus extend the family's host range to reptiles, amphibians, and , primarily in tropical and aquatic environments. Herpetohepadnavirus includes Tibetan frog hepatitis B virus (TFHBV), identified in plateau frogs (Nanorana parkeri) in high-altitude regions of , with endogenous viral elements suggesting ancient infections in snakes and other reptiles across tropical areas. Metahepadnavirus species, such as bluegill hepatitis B virus (BGHBV), infect like (Lepomis macrochirus) in North American lakes, while novel metahepadnaviruses have been metagenomically detected in diverse teleosts including cichlids in lakes, herrings, (Cyprinus carpio), and eels, often tied to regional aquatic ecosystems and host migrations. No hepadnaviruses have been identified in hosts, underscoring their strict and co-evolutionary ties to vertebrate migrations and distributions.

Cell Tropism and Pathogenesis

Hepadnaviruses exhibit a strong for , the primary functional cells of the liver, mediated by the sodium taurocholate cotransporting polypeptide (NTCP) receptor on the hepatocyte surface. This receptor facilitates viral attachment and entry specifically in hepatocytes, restricting infection to the liver in most cases. While the viruses are hepatotropic, rare extrahepatic replication has been observed in chronic (HBV) infections, including in pancreatic tissues where viral DNA and antigens have been detected, potentially contributing to associated pathologies. The of hepadnaviral infections primarily involves immune-mediated liver damage rather than direct cytopathic effects from the virus itself. HBV and related viruses replicate efficiently in without causing cell , but the host's adaptive , particularly cytotoxic T lymphocytes targeting infected cells, leads to hepatocyte destruction and subsequent , , and . Persistence of the viral covalently closed circular DNA () in the serves as a stable template for ongoing transcription, enabling in approximately 5–10% of immunocompetent adults who fail to clear the virus. Hepadnaviruses possess oncogenic potential, with HBV's X protein (HBx) playing a key role by integrating into the host genome and dysregulating cellular pathways such as cell cycle progression, apoptosis inhibition, and epigenetic modifications that promote hepatocellular carcinoma (HCC). This integration often occurs randomly but frequently disrupts tumor suppressor genes or enhances oncogene expression, contributing to malignant transformation over years of chronic infection. Similar mechanisms are evident in animal models, where woodchuck hepatitis virus (WHV) infection leads to high rates of HCC through viral integration and X protein-mediated oncogenesis, mirroring HBV effects in humans.

References

  1. [1]
    ICTV Virus Taxonomy Profile: Hepadnaviridae - PMC - NIH
    The family Hepadnaviridae comprises small enveloped viruses with a partially double-stranded DNA genome of 3.0–3.4 kb. All family members express three sets ...Missing: authoritative | Show results with:authoritative
  2. [2]
    Family: Hepadnaviridae - ICTV
    The genus Avihepadnavirus comprises three species whose members infect birds and the genus Orthohepadnavirus comprises 12 species whose members infect mammals.Missing: authoritative | Show results with:authoritative
  3. [3]
    [DOC] 2023.014D.Hepadnaviridae_19renam_9nsp.docx - ICTV
    The introduction of the 7 new species in the genus Orthohepadnavirus and 2 new species in the genus Avihepadnavirus was done according to the species ...
  4. [4]
    Clinical Overview of Hepatitis B - CDC
    Aug 29, 2025 · Hepatitis B is caused by infection with HBV. HBV is a 40–42-nanometer enveloped virus classified in the Hepadnaviridae family. HBV contains a ...<|control11|><|separator|>
  5. [5]
    Hepadnaviridae - ViralZone
    A knowledge resource to understand virus diversity and a gateway to UniProtKB/Swiss-Prot viral entries.Missing: authoritative sources
  6. [6]
    Hepatitis B: The Virus and Disease - PMC - PubMed Central
    Hepatitis B virus (HBV) infects more than 300 million people worldwide and is a common cause of liver disease and liver cancer.
  7. [7]
    Hepadnaviridae - Taxonomy browser Taxonomy Browser () - NIH
    Lineage (full): Viruses; Riboviria; Pararnavirae; Artverviricota; Revtraviricetes; Blubervirales · Hepadnaviridae (hepatitis B-type viruses).
  8. [8]
    ICTV Virus Taxonomy Profile: Hepadnaviridae - Microbiology Society
    May 14, 2020 · The family Hepadnaviridae comprises small enveloped viruses with a partially double-stranded DNA genome of 3.0–3.4 kb.Missing: species | Show results with:species
  9. [9]
    Changes to virus taxonomy and to the International Code of Virus ...
    Jul 6, 2021 · This article reports the changes to virus taxonomy approved and ratified by the International Committee on Taxonomy of Viruses (ICTV) in March 2021.
  10. [10]
    Genus: Avihepadnavirus - ICTV
    Viruses classified in the species Duck hepatitis B virus have also been isolated from Sheld goose and Ross goose. A virus closely related to HHBV has been ...Distinguishing Features · Biology · Species Demarcation CriteriaMissing: Herpetic | Show results with:Herpetic
  11. [11]
    Genus: Herpetohepadnavirus - ICTV
    The virus Tibetan frog hepatitis B virus (TFHBV) is classified in the species Tibetan frog hepatitis B virus, which is the only species of the genus.
  12. [12]
    Genus: Metahepadnavirus | ICTV
    Metahepadnavirus is a genus within Hepadnaviridae, lacking the X-gene of orthohepandaviruses. BGHBV is the only species, found in bluegill.Missing: delineation | Show results with:delineation
  13. [13]
    Genus: Orthohepadnavirus | ICTV
    Family: Hepadnaviridae. Genus: Orthohepadnavirus. Distinguishing features. Viruses of this genus infect mammals, with a narrow host range for members of ...
  14. [14]
    [PDF] australia antigen and the biology of hepatitis b. - Nobel Prize
    AUSTRALIA ANTIGEN AND THE BIOLOGY OF. HEPATITIS B. Nobel Lecture, December 13, 1976 by. BARUCH S. BLUMBERG. The Institute for Cancer Research, The Fox ...
  15. [15]
    Medical Virology of Hepatitis B: how it began and where we are now
    In 1972, Swedish virologist Lars Magnius discovered, while looking for HBsAg subtypes, an additional marker, HBeAg, in HBsAg positive sera which helped to ...
  16. [16]
    [PDF] Ratification_1990.pdf - ICTV
    To name the family in proposal No 42, the Hepadnaviridae family. Paramyxovirus Study Group. 44. To establish an order comprising the three families of ...
  17. [17]
    Hepadnaviridae - ICTV
    Hepadnaviruses are spherical, occasionally pleomorphic, 42–50 nm in diameter, with no evident surface projections after negative staining.Genome Organization And... · Genus Orthohepadnavirus · Genus AvihepadnavirusMissing: realm Riboviria
  18. [18]
    Changes to virus taxonomy and the Statutes ratified by the ...
    Aug 20, 2020 · ... proposals to establish three realms for viruses with DNA genomes. ... Magnius LO (2019) Create three new genera in the family Hepadnaviridae ...
  19. [19]
    [DOC] 2019.008D.A.v1.Hepadnaviridae_3gen.docx - ICTV
    If no criteria have previously been established, and if there will now be more than one species in the genus, please state the demarcation criteria you are ...
  20. [20]
    Changes to virus taxonomy and the ICTV Statutes ratified by the ...
    Nov 3, 2024 · The 2024 round of taxonomy proposals saw the near completion of the mandated change of species names to a binomial format (i.e., genus + species ...Missing: Hepadnaviridae | Show results with:Hepadnaviridae
  21. [21]
    Species List: Hepadnaviridae - ICTV
    Species List: Hepadnaviridae. Virus names, the choice of exemplar isolates, and virus abbreviations, are not official ICTV designationsMissing: Artverviricota | Show results with:Artverviricota
  22. [22]
    Hepatitis B virus biology and life cycle - ScienceDirect.com
    Visualization of a 4-helix bundle in the hepatitis B virus capsid by cryo-electron microscopy. Nature, 386 (1997), pp. 91-94. View in Scopus Google Scholar.
  23. [23]
    Structural conservation of HBV-like capsid proteins over hundreds of ...
    Mar 22, 2023 · For both viruses the overall architecture of most capsids conforms to T = 4 icosahedral symmetry, formed by 120 dimers each. This is made ...
  24. [24]
    Native Hepatitis B Virions and Capsids Visualized by Electron ...
    Our working 3D structure of the HBV virion is a composite model that combines the T=4 icosahedral capsid shell with the envelope decorated with 160–200 surface ...
  25. [25]
    Prevention of Hepatitis B Virus Infection in the United States - CDC
    Jan 12, 2018 · HBV is a 40–42-nm enveloped virus classified in the Hepadnaviridae family. ... The first HepB vaccines consisted of plasma-derived HBsAg.
  26. [26]
    Biology of the hepatitis B virus (HBV) core and capsid assembly ...
    In infectious particles, the nucleocapsid is a T = 4 icosahedral core that is an assembly of the multimeric core protein (Cp), or HBV core antigen (HBcAg) ( ...
  27. [27]
    The Hepatitis B Virus Nucleocapsid—Dynamic Compartment ... - MDPI
    Counting the dimers per triangular face yields 4.5 for T = 3 and 6 for T = 4, hence totally 90 and 120 dimers, respectively. The model on the right shows ...
  28. [28]
    Structural basis for nuclear import of hepatitis B virus (HBV ...
    The nucleocapsid comprises a ~36-nm icosahedron with triangulation number T = 4, built by 240 copies of the core protein, Cp183 (5). HBV replication requires ...
  29. [29]
  30. [30]
  31. [31]
    The three types of particles visualized in the serum of a patient with...
    The hepatitis B virion (or Dane particle) is spherical and has a diameter of approximately 42 nm. It is enclosed in an outer envelope approximately 8 nm in ...<|control11|><|separator|>
  32. [32]
    Hepadnavirus Genome Replication and Persistence - PMC - NIH
    Hepadnaviruses (eg, hepatitis B) are unique viruses that replicate their genomes using a reverse transcriptase. Many details of their replication cycle are ...
  33. [33]
  34. [34]
    Illumina and Nanopore methods for whole genome sequencing of ...
    May 8, 2019 · ... genome, where GC content is 48–49.5%. To ... Illumina and Nanopore methods for whole genome sequencing of hepatitis B virus (HBV).
  35. [35]
    Complete nucleotide sequence of hepatitis B virus DNA of subtype ...
    The 3215-bp sequence showed the presence of genes for the surface antigen (226 amino acids) and core antigen (183 amino acids), in addition to two (long and ...
  36. [36]
    Molecular, Evolutionary, and Structural Analysis of the Terminal ...
    May 22, 2020 · It is concluded that the TP domain of HBV polymerase is comprised of seven subdomains (three unstructured loops and four helical regions)
  37. [37]
    Spacer Domain in Hepatitis B Virus Polymerase: Plugging a Hole or ...
    Hepatitis B virus (HBV) polymerase is divided into terminal protein, spacer, reverse transcriptase, and RNase domains. Spacer has previously been considered ...
  38. [38]
    Comparative Analysis of Hepatitis B Virus Polymerase Sequences ...
    HP is made up of four domains, including the terminal protein (TP), the spacer, the reverse transcriptase (RT), and the RNase H domains. A recently ...
  39. [39]
    Molecular, Evolutionary, and Structural Analysis of the Terminal ...
    May 22, 2020 · Downstream of the TP domain are the spacer, reverse transcriptase (RT), and RNase H domains (Figure 1). HBV Pol is similar in sequence and ...
  40. [40]
    Hepatitis B virus reverse transcriptase: diverse functions as classical ...
    The ca. 3.2-kb genome of HBV is replicated by a virally encoded polymerase (HP), a specialized reverse transcriptase (RT). HP uses the viral pregenomic ...
  41. [41]
    Predicted structure of the hepatitis B virus polymerase reveals ... - NIH
    The RT domain adopted the expected right‐hand shape of a DNA polymerase with fingers, palm, and thumb subdomains (Figure 2a). The conserved A‐E DNA polymerase ...
  42. [42]
    A Single Amino Acid in the Reverse Transcriptase Domain of ...
    HBV RT is composed of three subdomains, fingers (319 to 400 and 451 to 515, in blue), palm (401 to 450 and 516 to 610, in red), and thumb (611 to 700, in green) ...
  43. [43]
    Predicted structure of the hepatitis B virus polymerase reveals an ...
    Feb 17, 2022 · The spacer is followed by the catalytic core of the enzyme comprised of the RT and RNaseH domains. The RT domain (∼335 aa) carries the canonical ...
  44. [44]
    Hepatitis B Virus (HBV) Mutations Associated with Resistance ... - NIH
    The nucleoside analog lamivudine (2′,3′-dideoxy-3′-thiacytidine) has been shown to be very efficient in reducing both HIV and HBV replication by inhibiting the ...
  45. [45]
  46. [46]
    Hepatitis B virus genetic variants: biological properties and clinical ...
    Mar 13, 2013 · Initiation from the ATG codons of preS1, preS2, and S in the envelope gene generates the large (L), middle (M), and small (S) envelope proteins ...
  47. [47]
    Molecular Biology of the Hepatitis B Virus for Clinicians - PMC
    It has a partially double stranded DNA with highly complex genome organization, life cycle and natural history. Remarkably distinct from other DNA viruses, it ...
  48. [48]
    Engineering Hepadnaviruses as Reporter-Expressing Vectors - MDPI
    Compared to orthohepadnaviruses, avihepadnaviruses harbor a preS/S ORF, instead of preS1/preS2/S, that only encodes two forms of co-terminal envelope proteins, ...<|control11|><|separator|>
  49. [49]
    Hepatitis B Virus Genotypes and Variants - PMC - PubMed Central
    Based on different serological reactivities of HBsAg, HBV can be classified into four serotypes, adw, adr, ayw, and ayr (Le Bouvier et al. 1972; Tiollais et al.
  50. [50]
    Strategies to eliminate HBV infection - PMC - PubMed Central - NIH
    Noninfectious subviral particles (SVPs) share antigenic features of the virus envelope and are thought to presumably act as a decoy for the immune system [84].<|control11|><|separator|>
  51. [51]
    Hepatitis B Virus (HBV) Subviral Particles as Protective Vaccines ...
    The review provides an overview of the formation and assembly of the HBsAg SVPs and highlights the utilization of the particles in key effective vaccines.
  52. [52]
    The Hepatitis B Virus Interactome: A Comprehensive Overview - PMC
    ... subviral particles (Figure 1). These particles are non-infectious 22 nm spheres or filaments of variable length consisting solely of the HBsAg envelope protein ...
  53. [53]
    Hepatitis B Virus Entry into Cells - PMC - NIH
    This entry is thought to occur via endocytosis. However, the detailed mechanisms by which NTCP mediates HBV entry remain to be determined. It also remains ...
  54. [54]
    Kinetics of the bile acid transporter and hepatitis B virus receptor Na ...
    A further intriguing finding of the present study is that the myr-preS1 peptide-dependent attachment of HBV to NTCP and the bile acid transport function of NTCP ...
  55. [55]
    pH-independent Entry and Sequential Endosomal Sorting Are Major ...
    In this study, we explored the mode of virus entry using the duck hepatitis B virus (DHBV) and the primary hepatocyte infection model.
  56. [56]
    Hepatitis B Virus Entry into Cells - MDPI
    pH-independent entry and sequential endosomal sorting are major determinants of hepadnaviral infection in primary hepatocytes. Hepatology 2006, 44, 685–693 ...
  57. [57]
    Evolution of Hepatitis B Virus Receptor NTCP Reveals Differential ...
    Here, we suggest that NTCP may contribute to Orthohepadnavirus differential host specificity in mammals. In nonhominoid primates, the adaptive changes in NTCP ...
  58. [58]
    Evolution of Hepatitis B Virus Receptor NTCP Reveals Differential ...
    HBV-like viruses, named orthohepadnaviruses, also naturally infect nonhuman primates, rodents, and bats, but their pathogenicity and evolutionary history are ...
  59. [59]
    Mechanism of Hepatitis B Virus cccDNA Formation - PMC
    cccDNA biogenesis is a complex multiple-step process, which involves the nuclear transport of rcDNA, rcDNA repair and cccDNA chromatinization (Figure 1). Each ...
  60. [60]
  61. [61]
  62. [62]
  63. [63]
  64. [64]
    Hepatitis B viruses: Reverse transcription a different way
    ### Summary of Reverse Transcription in Hepadnaviruses vs. Retroviruses
  65. [65]
    Regulation of Hepadnavirus Reverse Transcription by Dynamic ...
    Reverse transcription, an essential step in the life cycle of all retroelements, is a complex, multistep process whose regulation is not yet clearly understood.Missing: review | Show results with:review
  66. [66]
  67. [67]
    Functional and Structural Dynamics of Hepadnavirus Reverse ...
    Reverse transcription in hepadnaviruses is primed by the viral reverse transcriptase (RT) (protein priming) and requires the interaction between the RT and ...
  68. [68]
    Quasispecies structure, cornerstone of hepatitis B virus infection
    The hepadnavirus family replicates by a reverse transcriptase that lacks proofreading activity, and this fact seems to justify their high mutation rate (3.2 ...
  69. [69]
    Assembly and Release of Hepatitis B Virus - PMC - NIH
    Capsid and Virion Structure. The structures of T = 4 capsids, formed by the assembly domain, Cp149, have been determined by cryo-EM and X-ray crystallography ( ...
  70. [70]
    Regulation of Hepatitis B Virus Virion Release and Envelopment ...
    These results suggest that interactions between the capsid and envelope proteins regulate one or more steps during virion secretion beyond initial capsid ...
  71. [71]
  72. [72]
  73. [73]
  74. [74]
    Article Deciphering the Origin and Evolution of Hepatitis B Viruses ...
    We speculate that the co-evolution of tetrapod hepadnaviruses with their hosts over geologic eras could be a direct consequence of their specialization to a ...
  75. [75]
    Hepatitis B Virus (HBV) X Gene Diversity and Evidence of ...
    Several recombination “hot spots” have been identified within the HBV genome, including PreS1/PreS2 (nt 3150–100), the 3′ end of S (nt 650–830), and both ends ...Missing: SX | Show results with:SX
  76. [76]
    Conserved recombination patterns across hepatitis B genotypes
    Jul 5, 2025 · HBV genomes have been categorized into ten genotypes (designated A-J) [6] based on a genome-wide pairwise nucleotide sequence divergence from ...<|control11|><|separator|>
  77. [77]
    Metagenomic analysis uncovers novel hepadnaviruses and ... - Nature
    Jul 9, 2025 · The discovery of novel hepadnaviruses in previously unexplored species holds promise for establishing practical animal models for hepadnaviral ...
  78. [78]
    Bat hepadnaviruses and the origins of primate hepatitis B viruses
    Finally, we re-evaluate the evolutionary origins of human hepatitis viruses and discuss the past and present zoonotic potential of their animal homologues.
  79. [79]
    Immune-Escape Hepatitis B Virus Mutations Associated with Viral ...
    Aug 24, 2019 · This review discusses the possible influence of the most frequently found immune-escape mutations on HBV reactivation.Missing: bonds | Show results with:bonds
  80. [80]
    Orthohepadnavirus - an overview | ScienceDirect Topics
    Rodent hepadnaviruses are carried by only one of the 33 extant rodent families, namely the Sciuridae [79]. Numbers at gray dots indicate time (in million years) ...
  81. [81]
    Identification of a novel orthohepadnavirus in pomona roundleaf ...
    Bats in Myanmar, Gabon, and Panama have been found to harbor diverse hepadnaviruses. Here, we report a novel hepadnavirus in 4 of 20 pomona roundleaf bats ...
  82. [82]
    Identification and Characterization of Avihepadnaviruses Isolated ...
    The family Hepadnaviridae is divided into two genera, Orthohepadnavirus and Avihepadnavirus, each with restricted host specificity. Ortho (mammalian) ...
  83. [83]
    Genetic diversity and phylogeographic dynamics of avihepadnavirus
    May 1, 2024 · In the family of Hepadnaviridae, viruses are classified into five genera based on the host species, i.e., Avihepadnavirus, Orthohepadnavirus, ...
  84. [84]
    The Culprit Behind HBV-Infected Hepatocytes: NTCP - PMC
    Oct 28, 2024 · The entry of HBV into liver cells begins with the low-affinity binding of the pre-S1 domain on HBV's surface to HSPG on hepatocyte membranes.18, ...
  85. [85]
    Innovative HBV Animal Models Based on the Entry Receptor NTCP
    Jul 30, 2020 · Here, we review what is known about HBV entry through the NTCP receptor and highlight how this knowledge has been harnessed to build new animal models.
  86. [86]
    Pancreatic involvement in chronic viral hepatitis - PMC - NIH
    Pancreatic disease, asymptomatic in most cases, may represent an extrahepatic manifestation of chronic viral hepatitis.
  87. [87]
    Immune-mediated Liver Injury in Hepatitis B Virus Infection - NIH
    Aug 26, 2015 · This review describes our current knowledge of the immune-mediated pathogenesis of HBV infection and the role of immune cells in the liver injury during ...
  88. [88]
    Pathogenesis of Hepatitis B Virus Infection - PMC - NIH
    Many studies suggest that HBV is not directly cytopathic for the infected hepatocyte [1–3]. For example, during the early phase of HBV infection in chimpanzees ...
  89. [89]
    In Vivo Model Systems for Hepatitis B Virus Research - PMC - NIH
    Studying cccDNA persistence, a vital component for chronic infection, has therefore been possible in chronically infected chimpanzees. This has enabled the ...
  90. [90]
    Hepatitis B virus X protein accelerates the development of hepatoma
    Accumulated evidence has shown that HBV X protein (HBx protein) is a multifunctional regulator with a crucial role in hepatocarcinogenesis.
  91. [91]
    Hepatitis B virus integration and hepatocarcinogenesis - ScienceDirect
    HBV promotes HCC development through direct and indirect mechanisms. HBV DNA integrates into the host genome during the initial stages of tumorigenesis, causing ...
  92. [92]
    Application of the woodchuck animal model for the treatment of ...
    This review describes woodchucks chronically infected with the woodchuck hepatitis virus (WHV) as an animal model for hepatocarcinogenesis and treatment of ...